Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Endoscopic obesity treatments under 10-Year microscope

NCT ID NCT05725967

Disease control Sponsor: Christopher C. Thompson, MD, MSc Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study will follow 5,000 adults who have had endoscopic procedures for weight loss, such as stomach stapling through a scope or gastric balloons. Researchers will track weight, blood pressure, diabetes, and cholesterol for up to 10 years to see how well these procedures work long-term. The goal is to better understand which treatments help people keep weight off and improve related health conditions.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Endoscopic procedures (e.g., sleeve gastroplasty, intragastric balloons, aspiration therapy)
What this could lead to
If successful, this could show which endoscopic procedures work best for long-term weight loss and reducing obesity-related health problems like diabetes and high blood pressure.
What could go wrong
This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may take up to 10 years and depend on participants staying in the study.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 5,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2022

Expected to finish

May 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult patients registered with Mass General Brigham affiliate facilities who have undergone an endoscopic primary obesity procedure, an endoscopic bariatric revision procedure, or a bariatric surgical procedure.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * patients from Mass General Brigham * any patient having an endoscopic primary obesity procedure * any patient having an endoscopic post-bariatric surgical revision procedure * any patient having a bariatric surgical procedure Exclusion Criteria: * patients without past surgical and medical history medical records in the Mass General Brigham system * patients unwilling to allow for medical record review at Mass General Brigham

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Abdominal obesity are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Abdominal Pain Anastomotic Leak Gastric Fistula gastric ulcer iatrogenic disease morbid obesity Obesity obesity disorder Obesity, Abdominal Postoperative Complications Weight Gain Weight Loss

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Abdominal obesity Abdominal pain Bariatric surgery candidate Complication of surgical procedure Complication of treatment Complication postoperative Delayed gastric emptying following procedure Fistula, gastric Leak, anastomotic Obesity Obesity associated disorder Obesity, morbid Roux-en-Y anastomosis site Ulcer, gastric Weight gain Weight loss

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Brigham and Women's Hospital

    Boston, Massachusetts, 02115, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.